• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
M7T
Click for more information
1.39% 35.5¢

MACH7 TECHNOLOGIES LIMITED - Announcements

Market Cap $127.8M  ! watchlist Created with Sketch. Add to my watchlist

Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The... Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The principal activity of the Company is the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution consists of a Vendor Neutral Archive (VNA) and data administration tools, which allow for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the cloud. Enterprise Diagnostic Viewing offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. It offers its solutions across North America, Asia Pacific, and the Middle East region.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
M7T Change in Substantial Shareholding from AEF19/09/24
M7T Sentara Selects Mach7 for PACS ModernisationPRICE SENSITIVE28/03/19
M7T Change in substantial holding from JMFG20/03/19
M7T Appendix 3B18/03/19
M7T Final Director's Interest Notice15/03/19
M7T Mach7 Restructuring to Achieve Cash-flow Break-EvenPRICE SENSITIVE11/03/19
M7T Change of Director's Interest Notice01/03/19
M7T Cleansing Notice01/03/19
M7T Appendix 3B01/03/19
M7T Change in substantial holding from OCP28/02/19
M7T Mach7's Half Year Results Strong Growth in Recurring RevenuePRICE SENSITIVE25/02/19
M7T Half Yearly Report and AccountsPRICE SENSITIVE25/02/19
M7T Shareholder Update31/01/19
M7T Q2 Quarterly Financial UpdatePRICE SENSITIVE31/01/19
M7T Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
M7T Cleansing Notice11/12/18
M7T Appendix 3B11/12/18
M7T Mach7 Completes Capital Raise to Fund GrowthPRICE SENSITIVE30/11/18
M7T Trading HaltPRICE SENSITIVE28/11/18
M7T Change of Director's Interest Notice x 222/11/18
M7T Appendix 3B16/11/18
M7T Results of Meeting12/11/18
M7T CEO Presentation - AGM 201812/11/18
M7T Change of Director's Interest Notice09/11/18
M7T Investor Presentation - Finance News Network07/11/18
M7T Cleansing Notice06/11/18
M7T Sentara Healthcare Selects Mach7 as PACS Vendor of ChoicePRICE SENSITIVE05/11/18
M7T Appendix 3B02/11/18
M7T Mach7 wins enterprise imaging contract with HAHKPRICE SENSITIVE29/10/18
M7T Appendix 4C - quarterlyPRICE SENSITIVE29/10/18
M7T Appendix 3B18/10/18
M7T Notice of Annual General Meeting/Proxy Form12/10/18
M7T Corporate Governance Statement and Appendix 4G12/10/18
M7T Annual Report to shareholders12/10/18
M7T Change of Director's Interest Notice03/10/18
M7T Mach7 Investor Presentation04/09/18
M7T Mach7 Announces FY2018 ResultsPRICE SENSITIVE24/08/18
M7T Preliminary Final ReportPRICE SENSITIVE24/08/18
M7T Mach7 Expands Business in QatarPRICE SENSITIVE23/08/18
M7T Response to Appendix 3Y Query15/08/18
M7T Initial Director's Interest Notice (for 2 Directors)09/08/18
M7T Final Director's Interest Notice (for 2 directors)09/08/18
M7T Change of Director's Interest Notice09/08/18
M7T Mach7 Partners with EnvoyAI08/08/18
M7T Appendix 3B06/08/18
M7T Director Appointments/Resignations03/08/18
M7T Results of General Meeting31/07/18
M7T CEO Presentation to Shareholders - General Meeting31/07/18
M7T Appendix 4C - quarterly and quarterly updatePRICE SENSITIVE31/07/18
M7T Notice of General Meeting/Proxy Form29/06/18
M7T Mach7 CEO Letter to Shareholders29/06/18
M7T Mach7 Wins Raleigh RadiologyPRICE SENSITIVE29/06/18
M7T Change of Director's Interest Notice22/05/18
M7T Mach7 and Client Outlook Partner to Deliver PACSPRICE SENSITIVE16/05/18
M7T Change of Director's Interest Notice10/05/18
M7T Mach7 Showcases Solutions at RadiologyAsia 201809/05/18
M7T Cleansing Notice07/05/18
M7T Appendix 3B07/05/18
M7T Changes to Company Secretary and Registered Office23/04/18
M7T Cleansing Notice18/04/18
M7T Appendix 3B18/04/18
M7T Mach7 Quarterly UpdatePRICE SENSITIVE12/04/18
M7T Appendix 4C - quarterlyPRICE SENSITIVE12/04/18
M7T Mach7 Establishes Industry Advisory Board21/03/18
M7T Half Year Results Presentation07/03/18
M7T Half Yearly Results AnnouncementPRICE SENSITIVE26/02/18
M7T Appendix 4D and Half Yearly ReportPRICE SENSITIVE26/02/18
M7T Change of Director's Interest Notice08/02/18
M7T Cleansing Notice07/02/18
M7T Appendix 3B07/02/18
M7T Investor Presentation16/01/18
M7T Appendix 4C - quarterlyPRICE SENSITIVE16/01/18
M7T Cleansing Notice12/01/18
M7T Appendix 3B12/01/18
M7T Change of Director's Interest Notice05/01/18
M7T Change of Director's Interest Notice x 411/12/17
M7T Cleansing Notice11/12/17
M7T Appendix 3B11/12/17
M7T Results of 2017 Annual General Meeting30/11/17
M7T CEO's presentation to shareholders at 2017 AGM30/11/17
M7T Sentara Healthcare Selects Mach7 for Data Migration ProjectPRICE SENSITIVE17/11/17
M7T Change of Director's Interest Notice17/11/17
M7T Cleansing Notice14/11/17
M7T Appendix 3B14/11/17
M7T Mach7 Partners With Zebra Medical Vision13/11/17
M7T Mach7 Brings Onboard New Institutional InvestorPRICE SENSITIVE13/11/17
M7T Change in substantial holding10/11/17
M7T Appendix 3B - Issue of Employee LTIP Options03/11/17
M7T Mach7 Quarterly UpdatePRICE SENSITIVE31/10/17
M7T Appendix 4C - quarterlyPRICE SENSITIVE31/10/17
M7T Notice of Annual General Meeting/Proxy Form30/10/17
M7T Appendix 4G and Corporate Governance Statement30/10/17
M7T Annual Report to shareholders30/10/17
M7T CEO Letter to Shareholders23/10/17
M7T Initial Director's Interest Notice27/09/17
M7T Appointment of Chief Executive Officer to the BoardPRICE SENSITIVE25/09/17
M7T Mach7 signs Agreement with Uni. of Vermont Medical CentrePRICE SENSITIVE22/09/17
M7T Investor Presentation19/09/17
M7T Appendix 3B - Issue of Performance Rights to CEO29/08/17
M7T Mach7 Financial Results for the Year Ended 30 June 201728/08/17
M7T Change in Substantial Shareholding from AEF
19/09/24
M7T Sentara Selects Mach7 for PACS Modernisation
28/03/19PRICE SENSITIVE
M7T Change in substantial holding from JMFG
20/03/19
M7T Appendix 3B
18/03/19
M7T Final Director's Interest Notice
15/03/19
M7T Mach7 Restructuring to Achieve Cash-flow Break-Even
11/03/19PRICE SENSITIVE
M7T Change of Director's Interest Notice
01/03/19
M7T Cleansing Notice
01/03/19
M7T Appendix 3B
01/03/19
M7T Change in substantial holding from OCP
28/02/19
M7T Mach7's Half Year Results Strong Growth in Recurring Revenue
25/02/19PRICE SENSITIVE
M7T Half Yearly Report and Accounts
25/02/19PRICE SENSITIVE
M7T Shareholder Update
31/01/19
M7T Q2 Quarterly Financial Update
31/01/19PRICE SENSITIVE
M7T Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
M7T Cleansing Notice
11/12/18
M7T Appendix 3B
11/12/18
M7T Mach7 Completes Capital Raise to Fund Growth
30/11/18PRICE SENSITIVE
M7T Trading Halt
28/11/18PRICE SENSITIVE
M7T Change of Director's Interest Notice x 2
22/11/18
M7T Appendix 3B
16/11/18
M7T Results of Meeting
12/11/18
M7T CEO Presentation - AGM 2018
12/11/18
M7T Change of Director's Interest Notice
09/11/18
M7T Investor Presentation - Finance News Network
07/11/18
M7T Cleansing Notice
06/11/18
M7T Sentara Healthcare Selects Mach7 as PACS Vendor of Choice
05/11/18PRICE SENSITIVE
M7T Appendix 3B
02/11/18
M7T Mach7 wins enterprise imaging contract with HAHK
29/10/18PRICE SENSITIVE
M7T Appendix 4C - quarterly
29/10/18PRICE SENSITIVE
M7T Appendix 3B
18/10/18
M7T Notice of Annual General Meeting/Proxy Form
12/10/18
M7T Corporate Governance Statement and Appendix 4G
12/10/18
M7T Annual Report to shareholders
12/10/18
M7T Change of Director's Interest Notice
03/10/18
M7T Mach7 Investor Presentation
04/09/18
M7T Mach7 Announces FY2018 Results
24/08/18PRICE SENSITIVE
M7T Preliminary Final Report
24/08/18PRICE SENSITIVE
M7T Mach7 Expands Business in Qatar
23/08/18PRICE SENSITIVE
M7T Response to Appendix 3Y Query
15/08/18
M7T Initial Director's Interest Notice (for 2 Directors)
09/08/18
M7T Final Director's Interest Notice (for 2 directors)
09/08/18
M7T Change of Director's Interest Notice
09/08/18
M7T Mach7 Partners with EnvoyAI
08/08/18
M7T Appendix 3B
06/08/18
M7T Director Appointments/Resignations
03/08/18
M7T Results of General Meeting
31/07/18
M7T CEO Presentation to Shareholders - General Meeting
31/07/18
M7T Appendix 4C - quarterly and quarterly update
31/07/18PRICE SENSITIVE
M7T Notice of General Meeting/Proxy Form
29/06/18
M7T Mach7 CEO Letter to Shareholders
29/06/18
M7T Mach7 Wins Raleigh Radiology
29/06/18PRICE SENSITIVE
M7T Change of Director's Interest Notice
22/05/18
M7T Mach7 and Client Outlook Partner to Deliver PACS
16/05/18PRICE SENSITIVE
M7T Change of Director's Interest Notice
10/05/18
M7T Mach7 Showcases Solutions at RadiologyAsia 2018
09/05/18
M7T Cleansing Notice
07/05/18
M7T Appendix 3B
07/05/18
M7T Changes to Company Secretary and Registered Office
23/04/18
M7T Cleansing Notice
18/04/18
M7T Appendix 3B
18/04/18
M7T Mach7 Quarterly Update
12/04/18PRICE SENSITIVE
M7T Appendix 4C - quarterly
12/04/18PRICE SENSITIVE
M7T Mach7 Establishes Industry Advisory Board
21/03/18
M7T Half Year Results Presentation
07/03/18
M7T Half Yearly Results Announcement
26/02/18PRICE SENSITIVE
M7T Appendix 4D and Half Yearly Report
26/02/18PRICE SENSITIVE
M7T Change of Director's Interest Notice
08/02/18
M7T Cleansing Notice
07/02/18
M7T Appendix 3B
07/02/18
M7T Investor Presentation
16/01/18
M7T Appendix 4C - quarterly
16/01/18PRICE SENSITIVE
M7T Cleansing Notice
12/01/18
M7T Appendix 3B
12/01/18
M7T Change of Director's Interest Notice
05/01/18
M7T Change of Director's Interest Notice x 4
11/12/17
M7T Cleansing Notice
11/12/17
M7T Appendix 3B
11/12/17
M7T Results of 2017 Annual General Meeting
30/11/17
M7T CEO's presentation to shareholders at 2017 AGM
30/11/17
M7T Sentara Healthcare Selects Mach7 for Data Migration Project
17/11/17PRICE SENSITIVE
M7T Change of Director's Interest Notice
17/11/17
M7T Cleansing Notice
14/11/17
M7T Appendix 3B
14/11/17
M7T Mach7 Partners With Zebra Medical Vision
13/11/17
M7T Mach7 Brings Onboard New Institutional Investor
13/11/17PRICE SENSITIVE
M7T Change in substantial holding
10/11/17
M7T Appendix 3B - Issue of Employee LTIP Options
03/11/17
M7T Mach7 Quarterly Update
31/10/17PRICE SENSITIVE
M7T Appendix 4C - quarterly
31/10/17PRICE SENSITIVE
M7T Notice of Annual General Meeting/Proxy Form
30/10/17
M7T Appendix 4G and Corporate Governance Statement
30/10/17
M7T Annual Report to shareholders
30/10/17
M7T CEO Letter to Shareholders
23/10/17
M7T Initial Director's Interest Notice
27/09/17
M7T Appointment of Chief Executive Officer to the Board
25/09/17PRICE SENSITIVE
M7T Mach7 signs Agreement with Uni. of Vermont Medical Centre
22/09/17PRICE SENSITIVE
M7T Investor Presentation
19/09/17
M7T Appendix 3B - Issue of Performance Rights to CEO
29/08/17
M7T Mach7 Financial Results for the Year Ended 30 June 2017
28/08/17
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
35.5¢ 		Change
-0.005(1.39%) 		Mkt cap ! $127.8M
Open High Low Value Volume
35.5¢ 35.8¢ 35.0¢ $163.8K 461.2K

Buyers (Bids)

No. Vol. Price($)
17 203974 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 68677 4
View Market Depth
Last trade - 15.51pm 21/11/2024 (20 minute delay) ?
Last
35.5¢ 		  Change
-0.005 ( 0.00 %)
Open High Low Volume
35.5¢ 35.5¢ 35.0¢ 42450
Last updated 15.51pm 21/11/2024 ?
M7T (ASX) Chart

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.